橘荔散结丸有效部位对子宫肌瘤细胞增殖、凋亡及相关因子表达的影响
|
摘要
目的：探讨橘荔散结丸各提取部位对子宫肌瘤细胞增殖、凋亡及PR-A、EGF、EGFR表达水平的影响,明确其具体有效部位,为药物筛选、精简处方奠定基础。
方法：
1.采用胶原酶消化法对人子宫肌瘤细胞进行原代培养。
2.采用现代技术提取橘荔散结丸的化学成分群。
3.运用MTT法、流式细胞术、免疫细胞化学、免疫细胞荧光、酶联免疫等技术检测橘荔散结丸干预后子宫肌瘤细胞的增殖、凋亡、PR-A、EGF及EGFR的表达变化。
结果：
1.成功培养了人子宫肌瘤细胞。
2.与空白对照组相比：1)橘荔散结丸醇提物、水提醇沉液、水提醇沉物及挥发油组OD值均显著降低,差异有统计学意义(p<0.05),呈浓度依赖关系(p<0.05)。2)橘荔散结丸各提取部位组的凋亡率呈上升趋势,其中醇提物组的凋亡率上升显著,有统计学意义(p<0.05)；其他各提取部位组凋亡率的差异无统计学意义(p>0.05)。3)各橘荔散结丸提取部位组的PR-A阳性表达细胞的MOD呈显著降低,差异有统计学意义(p<0.05)。4)高浓度醇提物、水提醇沉液及挥发油组EGF分泌均显著下降,差异有统计学意义(p<0.05)；水提醇沉物组EGF分泌差异无统计学意义(p>0.05)。5)橘荔散结丸醇提物、水提醇沉液、水提醇沉物及挥发油组EGFR阳性表达细胞的MOD均显著降低,差异有统计学意义(p<0.05),挥发油组间成浓度依赖关系(p<0.05)。
3.与阳性对照RU486组相比：橘荔散结丸的醇提物、水提醇沉液、水提醇沉物及挥发油的高浓度组的EGFR表达显著降低,差异有统计学意义(p<0.05)。
结论：本研究表明降低子宫肌瘤细胞的增殖能力,诱导子宫肌瘤细胞凋亡而使其自然缩小或消退,降低子宫肌瘤细胞PR-A、EGFR的表达及EGF的分泌,可能是橘荔散结丸治疗子宫肌瘤的主要机理之一。而在橘荔散结丸的各组提取部位中,醇提物组的贡献较大。
(Hunan College of Traditional Chinese Medicine, Changsha,410007)
Objects:To explore the influence of Juli Sanjie Pill (JSP)on proliferation, apoptosis, progesterone receptor A (PR-A), EGF, EGFR expression level of Uterine Leiomyoma Cells (ULCs), observe the Effective parts, and provide a more scientific basis on Drug screening and streamlining the prescription.
Method:1. Uterine Leiomyoma Cells (ULCs) were digested with collagenase in primary culture.
2. The chemical composition of groups JSP was extracted by modern technology.
3. MTT, Flow cytometry, immunocytochemistry, immunofluorescence and euzymelinked immunosorbent assay (ELISA) were performed to observe the expression and changes on proliferation, apoptosis, PR-A, EGF, EGFR of ULCs, which were interved by JSP.
Result:1. ULCs were successfully cultured.
2.1) Compared with the blank group, OD of the alcohol extraction group. the water extraction and alcohol precipitation liquid group、the sediments from the water and alcohol group and the volatile oil group of JSP were significantly lower and their difference which was a dose-dependent was statistically significant (p<0.05).2) There was significant difference between the blank group and the alcohol extraction group in the rate of apoptosis (p<0.05), and there was no statistical significance in other extracts group of JPS (p>0.05). However, compared with the blank group, the rate of apoptosis in the four group of JPS grown more quickly.3) The difference was significant difference between the blank group and the four group of JPS in the MOD expression of ULCs where PR-A was positive (p<0.05).4) Compared with the blank group, the secretion of EGF in the high concentrations of the extraction group、the water extraction and alcohol precipitation liquid group and the volatile oil group of JSP were significantly decreased and the difference was statistically significant (p<0.05), but there was no significant difference between the blank group and the sediments from the water and alcohol group (p>0.05).5) The four group of JPS were significantly lower EGFR expression comparing with the blank group (p<0.05), and the EGFR expression of the two volatile oil group was significantly different (p<0.05).
3. Compared with the RU486 group, EGFR of the alcohol extraction group、the water extraction and alcohol precipitation liquid group、the sediments from the water and alcohol group and the volatile oil group of JSP were significantly lower (p<0.05).
Conclusion:It indicates that it is one of mechanisms for Juli Sanjie Pill (JSP) to treat Uterine Leiomyoma to induce apoptosis of the ULCs, make it spontaneous regression, make PR-A、EGFR and EGF fall in ULCs. The role of the extraction group was more significant.
方法：
1.采用胶原酶消化法对人子宫肌瘤细胞进行原代培养。
2.采用现代技术提取橘荔散结丸的化学成分群。
3.运用MTT法、流式细胞术、免疫细胞化学、免疫细胞荧光、酶联免疫等技术检测橘荔散结丸干预后子宫肌瘤细胞的增殖、凋亡、PR-A、EGF及EGFR的表达变化。
结果：
1.成功培养了人子宫肌瘤细胞。
2.与空白对照组相比：1)橘荔散结丸醇提物、水提醇沉液、水提醇沉物及挥发油组OD值均显著降低,差异有统计学意义(p<0.05),呈浓度依赖关系(p<0.05)。2)橘荔散结丸各提取部位组的凋亡率呈上升趋势,其中醇提物组的凋亡率上升显著,有统计学意义(p<0.05)；其他各提取部位组凋亡率的差异无统计学意义(p>0.05)。3)各橘荔散结丸提取部位组的PR-A阳性表达细胞的MOD呈显著降低,差异有统计学意义(p<0.05)。4)高浓度醇提物、水提醇沉液及挥发油组EGF分泌均显著下降,差异有统计学意义(p<0.05)；水提醇沉物组EGF分泌差异无统计学意义(p>0.05)。5)橘荔散结丸醇提物、水提醇沉液、水提醇沉物及挥发油组EGFR阳性表达细胞的MOD均显著降低,差异有统计学意义(p<0.05),挥发油组间成浓度依赖关系(p<0.05)。
3.与阳性对照RU486组相比：橘荔散结丸的醇提物、水提醇沉液、水提醇沉物及挥发油的高浓度组的EGFR表达显著降低,差异有统计学意义(p<0.05)。
结论：本研究表明降低子宫肌瘤细胞的增殖能力,诱导子宫肌瘤细胞凋亡而使其自然缩小或消退,降低子宫肌瘤细胞PR-A、EGFR的表达及EGF的分泌,可能是橘荔散结丸治疗子宫肌瘤的主要机理之一。而在橘荔散结丸的各组提取部位中,醇提物组的贡献较大。
(Hunan College of Traditional Chinese Medicine, Changsha,410007)
Objects:To explore the influence of Juli Sanjie Pill (JSP)on proliferation, apoptosis, progesterone receptor A (PR-A), EGF, EGFR expression level of Uterine Leiomyoma Cells (ULCs), observe the Effective parts, and provide a more scientific basis on Drug screening and streamlining the prescription.
Method:1. Uterine Leiomyoma Cells (ULCs) were digested with collagenase in primary culture.
2. The chemical composition of groups JSP was extracted by modern technology.
3. MTT, Flow cytometry, immunocytochemistry, immunofluorescence and euzymelinked immunosorbent assay (ELISA) were performed to observe the expression and changes on proliferation, apoptosis, PR-A, EGF, EGFR of ULCs, which were interved by JSP.
Result:1. ULCs were successfully cultured.
2.1) Compared with the blank group, OD of the alcohol extraction group. the water extraction and alcohol precipitation liquid group、the sediments from the water and alcohol group and the volatile oil group of JSP were significantly lower and their difference which was a dose-dependent was statistically significant (p<0.05).2) There was significant difference between the blank group and the alcohol extraction group in the rate of apoptosis (p<0.05), and there was no statistical significance in other extracts group of JPS (p>0.05). However, compared with the blank group, the rate of apoptosis in the four group of JPS grown more quickly.3) The difference was significant difference between the blank group and the four group of JPS in the MOD expression of ULCs where PR-A was positive (p<0.05).4) Compared with the blank group, the secretion of EGF in the high concentrations of the extraction group、the water extraction and alcohol precipitation liquid group and the volatile oil group of JSP were significantly decreased and the difference was statistically significant (p<0.05), but there was no significant difference between the blank group and the sediments from the water and alcohol group (p>0.05).5) The four group of JPS were significantly lower EGFR expression comparing with the blank group (p<0.05), and the EGFR expression of the two volatile oil group was significantly different (p<0.05).
3. Compared with the RU486 group, EGFR of the alcohol extraction group、the water extraction and alcohol precipitation liquid group、the sediments from the water and alcohol group and the volatile oil group of JSP were significantly lower (p<0.05).
Conclusion:It indicates that it is one of mechanisms for Juli Sanjie Pill (JSP) to treat Uterine Leiomyoma to induce apoptosis of the ULCs, make it spontaneous regression, make PR-A、EGFR and EGF fall in ULCs. The role of the extraction group was more significant.
引文
[1]乐杰.妇产科学[M].第7版.北京： 人民卫生出版社.2008.1：269-272.
[2]石一复主编.子宫肌瘤现代诊疗[M].北京：人民军医出版社,2007.6：9-10.
[3]钱金花,郭新华,于云英.子宫肌瘤组织表皮生长因子及其受体的检测[J].齐鲁医学杂志.2003,18(3)：230-232.
[4]李卫平,严隽鸿,林其德.表皮生长因子受体与子宫平滑肌瘤的关系[J].上海第二医科大学学报.2003.23(2)：131-133.
[5]Blake RE. Leiomyomata uteri:hormonal and molecular determinants of growth [J]. Journal of The National Medical Association.2007,99 (10):1170-1184.
[6]Nisolle M; Gillerot S; Casanas-Roux F, et al. Immunohistochemical study of the proliferation index, estrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy[J]. Human Reproduction.1999.14 (11):2844-2850.
[7]陈贵安,张丽珠.子宫肌瘤与组织胞浆内雌、孕激素受体含量及血内雌二醇、孕酮水平关系的探讨[J].中华妇产科杂志.1984.19(2)：88.
[8]陈小锋,王培训,罗元恺,等.橘荔散结丸治疗子宫肌瘤的NK细胞活性观察[J].中成药,1988(11)：21-22.
[9]罗清华,冯金英,陈碧云.橘荔散结丸治疗子宫肌瘤150例临床体会[J].新中医.1990(8)：26.
[10]李坤寅,罗颂平,匡忠生,等.橘荔散结丸对子宫肌瘤雌、孕激素受体水平的影响[J].南京中医药大学学报.2005.21(4)：228-229.
[11]李坤寅,王文君,罗颂平.橘荔散结丸对子宫肌瘤孕激素受体及其基因表达的影响[J].新中医2005.37(5)：32-33.
[12]李坤寅,关永格,王慧颖.从橘荔散结丸浅析罗元恺教授治疗子宫肌瘤之经验[J].中华中医药学刊.2008.26(2)：236-238.
[13]李坤寅,卢朝霞,关永格,等.橘荔散结丸对子宫肌瘤雌激素受体表达的影响[J].广州中医药大学学报.2008.25(6)：498-502.
[14]李坤寅,关永格,卢朝霞,等.橘荔散结丸对子宫肌瘤组织芳香化酶P450表达影响[J].陕西中医.2009.30(11)：1549-1551.
[15]杨幼林,郑淑蓉.孕激素与子宫肌瘤发病的关系[J].中华妇产科杂志,1996.31(3)：184-185.
[16]吴际,程云英.子宫肌瘤组织雌、孕激素受体及细胞增殖相关抗原与激素及细胞核体关系的探讨[J].中华妇产科杂志,1995.30(10)：603-607.
[17]刘曼华,程英,管卫群,等.血清激素水平和子宫ER、PR含量与子宫肌瘤生长的关系[J].苏州大学学报(医学版).2003.23(6)：683-685.
[18]丁佩芳,程忠平,蒋允凯.ER、PR、PCNA、C-CrbB-2在子宫肌瘤中的表达及其临床意义[J].现代诊断与治疗.2003.14(3)：137-140.
[19]Saruhan BG, Ozdemir N. Effect of ovariectomy and of estrogen treatment on the adrenal gland and bodyweight in rats [J]. Saudi Med J, 2005,26(11):1705-1709.
[20]Katzenellenbogen BS, Katzenellbogen JM. Estrogen receptor transcription and Tran activation:Estrogen receptor alpha and estrogen receptor beta:regulation by selective estrogen receptor modulators and importance in breast cancer [J]. Breast Cancer Res.2000,2(5):335-344.
[21]Kovacs KA, Oszter A, Gocze P, et al. Comparative analysis of cyclin D1 and estrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium [J]. Mol Hum Reprod.2001,7(11):1085-1091.
[22]张桂香,赵学东,王文勇,等.雌激素受体α、β亚型在子宫平滑肌瘤中的表达特征[J].解剖学杂志.2005,28(3)：285-286.
[23]Hovland AR, Powell RL, Takimoto GS, et al. An N terminal inhibitory function, IF, Suppresses transcription by the A isoform but not the B isoform of human progesterone receptors [J]. J Biol Chem,1998,273(10):5455-5460.
[24]高嵘,盛修贵,荣风年,等.米非司酮对子宫肌瘤及子宫正常肌层组织中 PR亚型、VEGF、MVD的影响[J].山东医药.2006.46(23)：39-40.
[25]Dixon D, He H. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium[J]. Environ Health Perspect 2000; 108 Suppl 5:795.
[26]Martin Chaver EB, Brum IS, Stoll J, et al. Insulin-like growth factor I receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma[J]. Gynecol Obstet Invest,2004, 57(4):210-213.
[27]MARUO T,MATSUO H,SAMOTO T,et al.Effects of progesterone on growth factor expression in human uterine leiomyoma [J]. Steroids, 2003,68(10-13):817-824.
[28]Mcbean JH et al. J Clin Endocrinol Metab,1997,82(5):1467-1471.
[29]李卫平,林其德,严隽鸿,等.子宫平滑肌瘤细胞增殖与表皮生长因子受体关系研究子宫肌瘤细胞膜上[J].上海医学.2002,25(4)：202-204.
[30]钱金花,郭新华,于云英.子宫肌瘤组织表皮生长因子及其受体的检测[J].齐鲁医学杂志.2003,18(3)：230-232.
[31]Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor(EGF)and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata[J].Fertil Steril,1991,56:997-1002.
[32]蔡云朗,沈扬,任慕兰.米非司酮对子宫肌瘤组织中雌、孕激素受体及表皮生长因子受体的影响[J].现代医学.2007,35(4)：299-303.
[33]杨业洲,梅立,胡家骆,等.子宫肌瘤患者外周静脉与子宫静脉血管内皮细胞生长因子水平测定及临床意义[J].实用妇产科杂志.2005,21(7)：411-412.
[34]王慧香,岳瑛,周新,等.血管内皮生长因子受体1及孕激素受体在子宫肌瘤中的表达[J].中国实验诊断学,2005；9(6)：906-909.
[35]郝国荣,杜建层,李素果.症状性子宫肌瘤子宫内膜中VEGF、bFGF表达的实验研究[J].河北医药.2007,29(8)：799-801.
[36]纪巍,辛晓燕,陈必良.胰岛素样生长因子1及其受体对子宫肌瘤生长的影响[J].中医肿瘤临床与康复,2003；10(1)：24-26.
[37]余云云,李晓芹,钱金花,等.子宫肌瘤组织EGFR受体与IGF-1R的定位及定量分析[J].放射免疫学杂志,2003；16(6)：326-327.
[38]王惠兰,白会敏,陈素琴,等.转化生长因子β 1、β 3及其受体βRlR2mRNA在子宫肌瘤组织中的表达[J].中国实用妇科与产科杂志,2004;2(3)：171-173.
[39]杨进,宋伯来,潘石蕾,等.子宫肌瘤患者细胞免疫状态的研究及临床价值[J].广东医学,1993；14(6)：337.
[40]黄含英,陈雪芬,郑捷.子宫肌瘤患者自然杀伤细胞活性的改变[J].中华妇产科杂志,1990；25(5)：358.
[41]黎清,徐建平,罗惠娟.凋亡基因Caspase-3在子宫肌瘤中的表达及相关性研究[J].2007,28(6)：605-606.
[42]张志凌,张怡,徐碧泉.BCL-2和增殖细胞核抗原在子宫肌瘤中的表达[J].湖南医科大学学报.2001.11(6)：15-16.
[43]冯琼,潘庆宏,雷英,等.胶质瘤p27kipl、bc1-2和PCNA蛋白的表达[J].实用癌症杂志2003.18(5)：476-480.
[44]吕祝武.子宫肌瘤中bc1-2基因的表达及意义[J].陕西医学杂 志.2002：31(8)：705-706.
[45]Fujii S, Nakashima N, Okamura H, et al. Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced byestrogen. Expevimental appnach to leiomyomatosis pevtorealis disseminate [J]. Am J Obstet Gynecol.1981,139(2):164-172.
[46]刘文苓,肖承惊,赵凤志.肌瘤内消制剂对子宫肌瘤大鼠雌孕激素水平及受体表达影响[J].中医药学刊.2003,21(6)：867-858.
[47]朱焰,邱小燕,吴建辉,等.子宫肌瘤动物模型的建立[J].中国药理学通报.2006,22(3)：374-378.
[48]李冬华.子宫肌瘤大鼠模型制备方法之比较[J].中国现代医学杂志.2005,15(24)：3700-3702,3706.
[49]Strawn EY Jr, Novy MJ, Burry KA, et al. Insulin-like growth factor I promotes leiomyoma cell growth in vitro[J]. Am J Obstet Gynecol. 2005,172(6):1837-1843.
[50]徐青,仇黎丽,徐昌芬,等.子宫平滑肌瘤细胞原代培养及鉴定.南京医科大学学报.2007.9(27)：967-969.
[51]卫爱民,任慕兰,陈锡玲.米非司酮对子宫肌瘤培养细胞雌、孕激素受体和表皮生长因子受体表达的影响[J].南京铁道医学院学报.2004,23(6)：370-372.
[52]杨慧,田李军,耿永红.益气逐瘀法治疗围绝经期子宫肌瘤的临床观察[J].辽宁中医杂志.2008.35(5)：724-725.
[53]陈柏莲.消(?)汤治疗子宫肌瘤100例临床观察[J].四川中 医.2008.26(3)：78-79.
[54]尤昭玲,王若光,郑其昌,等.益气化瘀法对子宫肌瘤患者血清IL-2 R含量影响研究[J].中国实验方剂学杂志,2000.6(2)：60-62.
[55]李云霞.中药灌肠治疗子宫肌瘤.光明中医.2008,23(5)：631.
[56]盛丽,曲延华,王京喜,等.火针治疗子宫肌瘤50例临床观察.中国针灸.1998,3：172-173.
[57]林明花,王照浩.耳穴贴压配合温针灸治疗子宫肌瘤52例临床观察,中国针灸.1998：9.
[58]徐晔.探讨米非司酮配伍内美通与长效GnRH-a治疗子宫肌瘤的比较[J].齐齐哈尔医学院学报.2007.28(19)：2330-2331.
[59]张杰.达那唑治疗子宫肌瘤32例近期效果[J].广东医学.1998.19(6)：463-464.
[60]金英,刘淑红,王晶.米非司酮对子宫肌瘤及子宫肌层组织中ER、PR、VEGF和MVD表达的影响[J].山东医药.2008.48(38)：85-86.
[61]罗元恺.子宫肌瘤的中医治疗[J].新中医.1992,24(8)：18-19.
[62]X. Di, L. Yu, A.B. Moore, et al. A low concentration of genistein induces estrogen receptoralpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells [J]. Human Reproduction.2008,23(8):1873-1883.
[63]Nilo Bozzini, Consuelo J. Rodrigues, Domingos A. Petti, et al. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure [J]. Acta Obstet Gynecol Scand 2003; 82: 330-334.
[64]Chwalisz K; Larsen L; Mattia-Goldberg C, et al. A randomized controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyoma[J]. Fertility And Sterility. 2007,87(6):1399-1412.
[65]刘玉琴.细胞培养实验手册[M].北京：人民军医出版社.2009,6：3-5.
[66]李珍,赵志亮,郭述真.人子宫平滑肌细胞的原代培养[J].山西医药杂志.2007,36(12)：1101-1102.
[67]肖柳英,张丹,冯昭明,等.荔枝核对小鼠抗肿瘤作用研究[J].中药材,2004,7,27(4)：517.
[68]吕俊华,沈文娟,韦笑梅,等.荔枝核提取物对荷瘤小鼠肿瘤细胞Bax和Bc1-2蛋白表达的影响[J].中成药,2008,30(9)：1381.
[69]刘海洲,刘均红.海藻多糖的生物活性及医药应用研究新进展[J].化工科技市场,2005,8：29.
[70]王颖,马安伦,张惠珍,等.牡蛎提取物抗肿瘤作用的实验研究[J].中国海洋药物,1997,1：18-22.
[71]欧阳勇.莪术挥发油对实验动物子宫肌瘤抑制作用影响研究[J].中国现代药物应用,2008,12,2(24)：14.
[72]魏丽春,李庆军.益母草的药理与临床研究进展[J].西北药学杂志.2009,24(4)：333-335
[73]王一涛,王家葵,杨奎等.续断的药理学研究[J].中药药理与临床,1996(3)：20-23.
[74]黄爱华.宫瘤清含药血清对子宫肌瘤细胞ER、PR、EGFR、IGF-1R及肌瘤细胞凋亡的实验研究.成都中医药大学博士论文[J].2005.31-32.
[75]Kawaguchi K, Fujii S, Konishi, et al. Ultrastructural study of cultured muscle cell from uterine leiomyoma and myometrium under the influence of sex steroids [J]. Gynecol Oncol,1985,21:32.
[76]杨彦,王胜军,樊洁,等.不同浓度米非司酮对体外培养子宫肌瘤细胞生长的影响[J].江苏大学学报(医学版).2003,13(3)：123-125.
[77]司徒镇强,吴军正.细胞培养[M].第2版.西安：世界图书出版公司.2007.1：200-201.
[78]Bradon DD, Bethea CL, Strawn EY, et al. Progesterone receptor messenger ribonucleic acid and protein are over expressed in human uterine leiomyomas [J].AM J Obstet Gynecol,1993,169:78.
[79]Mcbean JH, Brumsted JR, Stirewalt WS. In vivo estrogen regulation of epidermal growth factor receptor in human endometrium[J]. J Clin Endocrinol Metab,1997,82(5):1467-1471.19.
[80]李卫平,林其德,严隽鸿,等.子宫平滑肌瘤细胞增殖与表皮生长因子受体关系研究子宫肌瘤细胞膜上[J].上海医学.2002,25(4)：202-204.
[2]石一复主编.子宫肌瘤现代诊疗[M].北京：人民军医出版社,2007.6：9-10.
[3]钱金花,郭新华,于云英.子宫肌瘤组织表皮生长因子及其受体的检测[J].齐鲁医学杂志.2003,18(3)：230-232.
[4]李卫平,严隽鸿,林其德.表皮生长因子受体与子宫平滑肌瘤的关系[J].上海第二医科大学学报.2003.23(2)：131-133.
[5]Blake RE. Leiomyomata uteri:hormonal and molecular determinants of growth [J]. Journal of The National Medical Association.2007,99 (10):1170-1184.
[6]Nisolle M; Gillerot S; Casanas-Roux F, et al. Immunohistochemical study of the proliferation index, estrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy[J]. Human Reproduction.1999.14 (11):2844-2850.
[7]陈贵安,张丽珠.子宫肌瘤与组织胞浆内雌、孕激素受体含量及血内雌二醇、孕酮水平关系的探讨[J].中华妇产科杂志.1984.19(2)：88.
[8]陈小锋,王培训,罗元恺,等.橘荔散结丸治疗子宫肌瘤的NK细胞活性观察[J].中成药,1988(11)：21-22.
[9]罗清华,冯金英,陈碧云.橘荔散结丸治疗子宫肌瘤150例临床体会[J].新中医.1990(8)：26.
[10]李坤寅,罗颂平,匡忠生,等.橘荔散结丸对子宫肌瘤雌、孕激素受体水平的影响[J].南京中医药大学学报.2005.21(4)：228-229.
[11]李坤寅,王文君,罗颂平.橘荔散结丸对子宫肌瘤孕激素受体及其基因表达的影响[J].新中医2005.37(5)：32-33.
[12]李坤寅,关永格,王慧颖.从橘荔散结丸浅析罗元恺教授治疗子宫肌瘤之经验[J].中华中医药学刊.2008.26(2)：236-238.
[13]李坤寅,卢朝霞,关永格,等.橘荔散结丸对子宫肌瘤雌激素受体表达的影响[J].广州中医药大学学报.2008.25(6)：498-502.
[14]李坤寅,关永格,卢朝霞,等.橘荔散结丸对子宫肌瘤组织芳香化酶P450表达影响[J].陕西中医.2009.30(11)：1549-1551.
[15]杨幼林,郑淑蓉.孕激素与子宫肌瘤发病的关系[J].中华妇产科杂志,1996.31(3)：184-185.
[16]吴际,程云英.子宫肌瘤组织雌、孕激素受体及细胞增殖相关抗原与激素及细胞核体关系的探讨[J].中华妇产科杂志,1995.30(10)：603-607.
[17]刘曼华,程英,管卫群,等.血清激素水平和子宫ER、PR含量与子宫肌瘤生长的关系[J].苏州大学学报(医学版).2003.23(6)：683-685.
[18]丁佩芳,程忠平,蒋允凯.ER、PR、PCNA、C-CrbB-2在子宫肌瘤中的表达及其临床意义[J].现代诊断与治疗.2003.14(3)：137-140.
[19]Saruhan BG, Ozdemir N. Effect of ovariectomy and of estrogen treatment on the adrenal gland and bodyweight in rats [J]. Saudi Med J, 2005,26(11):1705-1709.
[20]Katzenellenbogen BS, Katzenellbogen JM. Estrogen receptor transcription and Tran activation:Estrogen receptor alpha and estrogen receptor beta:regulation by selective estrogen receptor modulators and importance in breast cancer [J]. Breast Cancer Res.2000,2(5):335-344.
[21]Kovacs KA, Oszter A, Gocze P, et al. Comparative analysis of cyclin D1 and estrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium [J]. Mol Hum Reprod.2001,7(11):1085-1091.
[22]张桂香,赵学东,王文勇,等.雌激素受体α、β亚型在子宫平滑肌瘤中的表达特征[J].解剖学杂志.2005,28(3)：285-286.
[23]Hovland AR, Powell RL, Takimoto GS, et al. An N terminal inhibitory function, IF, Suppresses transcription by the A isoform but not the B isoform of human progesterone receptors [J]. J Biol Chem,1998,273(10):5455-5460.
[24]高嵘,盛修贵,荣风年,等.米非司酮对子宫肌瘤及子宫正常肌层组织中 PR亚型、VEGF、MVD的影响[J].山东医药.2006.46(23)：39-40.
[25]Dixon D, He H. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium[J]. Environ Health Perspect 2000; 108 Suppl 5:795.
[26]Martin Chaver EB, Brum IS, Stoll J, et al. Insulin-like growth factor I receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma[J]. Gynecol Obstet Invest,2004, 57(4):210-213.
[27]MARUO T,MATSUO H,SAMOTO T,et al.Effects of progesterone on growth factor expression in human uterine leiomyoma [J]. Steroids, 2003,68(10-13):817-824.
[28]Mcbean JH et al. J Clin Endocrinol Metab,1997,82(5):1467-1471.
[29]李卫平,林其德,严隽鸿,等.子宫平滑肌瘤细胞增殖与表皮生长因子受体关系研究子宫肌瘤细胞膜上[J].上海医学.2002,25(4)：202-204.
[30]钱金花,郭新华,于云英.子宫肌瘤组织表皮生长因子及其受体的检测[J].齐鲁医学杂志.2003,18(3)：230-232.
[31]Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor(EGF)and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata[J].Fertil Steril,1991,56:997-1002.
[32]蔡云朗,沈扬,任慕兰.米非司酮对子宫肌瘤组织中雌、孕激素受体及表皮生长因子受体的影响[J].现代医学.2007,35(4)：299-303.
[33]杨业洲,梅立,胡家骆,等.子宫肌瘤患者外周静脉与子宫静脉血管内皮细胞生长因子水平测定及临床意义[J].实用妇产科杂志.2005,21(7)：411-412.
[34]王慧香,岳瑛,周新,等.血管内皮生长因子受体1及孕激素受体在子宫肌瘤中的表达[J].中国实验诊断学,2005；9(6)：906-909.
[35]郝国荣,杜建层,李素果.症状性子宫肌瘤子宫内膜中VEGF、bFGF表达的实验研究[J].河北医药.2007,29(8)：799-801.
[36]纪巍,辛晓燕,陈必良.胰岛素样生长因子1及其受体对子宫肌瘤生长的影响[J].中医肿瘤临床与康复,2003；10(1)：24-26.
[37]余云云,李晓芹,钱金花,等.子宫肌瘤组织EGFR受体与IGF-1R的定位及定量分析[J].放射免疫学杂志,2003；16(6)：326-327.
[38]王惠兰,白会敏,陈素琴,等.转化生长因子β 1、β 3及其受体βRlR2mRNA在子宫肌瘤组织中的表达[J].中国实用妇科与产科杂志,2004;2(3)：171-173.
[39]杨进,宋伯来,潘石蕾,等.子宫肌瘤患者细胞免疫状态的研究及临床价值[J].广东医学,1993；14(6)：337.
[40]黄含英,陈雪芬,郑捷.子宫肌瘤患者自然杀伤细胞活性的改变[J].中华妇产科杂志,1990；25(5)：358.
[41]黎清,徐建平,罗惠娟.凋亡基因Caspase-3在子宫肌瘤中的表达及相关性研究[J].2007,28(6)：605-606.
[42]张志凌,张怡,徐碧泉.BCL-2和增殖细胞核抗原在子宫肌瘤中的表达[J].湖南医科大学学报.2001.11(6)：15-16.
[43]冯琼,潘庆宏,雷英,等.胶质瘤p27kipl、bc1-2和PCNA蛋白的表达[J].实用癌症杂志2003.18(5)：476-480.
[44]吕祝武.子宫肌瘤中bc1-2基因的表达及意义[J].陕西医学杂 志.2002：31(8)：705-706.
[45]Fujii S, Nakashima N, Okamura H, et al. Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced byestrogen. Expevimental appnach to leiomyomatosis pevtorealis disseminate [J]. Am J Obstet Gynecol.1981,139(2):164-172.
[46]刘文苓,肖承惊,赵凤志.肌瘤内消制剂对子宫肌瘤大鼠雌孕激素水平及受体表达影响[J].中医药学刊.2003,21(6)：867-858.
[47]朱焰,邱小燕,吴建辉,等.子宫肌瘤动物模型的建立[J].中国药理学通报.2006,22(3)：374-378.
[48]李冬华.子宫肌瘤大鼠模型制备方法之比较[J].中国现代医学杂志.2005,15(24)：3700-3702,3706.
[49]Strawn EY Jr, Novy MJ, Burry KA, et al. Insulin-like growth factor I promotes leiomyoma cell growth in vitro[J]. Am J Obstet Gynecol. 2005,172(6):1837-1843.
[50]徐青,仇黎丽,徐昌芬,等.子宫平滑肌瘤细胞原代培养及鉴定.南京医科大学学报.2007.9(27)：967-969.
[51]卫爱民,任慕兰,陈锡玲.米非司酮对子宫肌瘤培养细胞雌、孕激素受体和表皮生长因子受体表达的影响[J].南京铁道医学院学报.2004,23(6)：370-372.
[52]杨慧,田李军,耿永红.益气逐瘀法治疗围绝经期子宫肌瘤的临床观察[J].辽宁中医杂志.2008.35(5)：724-725.
[53]陈柏莲.消(?)汤治疗子宫肌瘤100例临床观察[J].四川中 医.2008.26(3)：78-79.
[54]尤昭玲,王若光,郑其昌,等.益气化瘀法对子宫肌瘤患者血清IL-2 R含量影响研究[J].中国实验方剂学杂志,2000.6(2)：60-62.
[55]李云霞.中药灌肠治疗子宫肌瘤.光明中医.2008,23(5)：631.
[56]盛丽,曲延华,王京喜,等.火针治疗子宫肌瘤50例临床观察.中国针灸.1998,3：172-173.
[57]林明花,王照浩.耳穴贴压配合温针灸治疗子宫肌瘤52例临床观察,中国针灸.1998：9.
[58]徐晔.探讨米非司酮配伍内美通与长效GnRH-a治疗子宫肌瘤的比较[J].齐齐哈尔医学院学报.2007.28(19)：2330-2331.
[59]张杰.达那唑治疗子宫肌瘤32例近期效果[J].广东医学.1998.19(6)：463-464.
[60]金英,刘淑红,王晶.米非司酮对子宫肌瘤及子宫肌层组织中ER、PR、VEGF和MVD表达的影响[J].山东医药.2008.48(38)：85-86.
[61]罗元恺.子宫肌瘤的中医治疗[J].新中医.1992,24(8)：18-19.
[62]X. Di, L. Yu, A.B. Moore, et al. A low concentration of genistein induces estrogen receptoralpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells [J]. Human Reproduction.2008,23(8):1873-1883.
[63]Nilo Bozzini, Consuelo J. Rodrigues, Domingos A. Petti, et al. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure [J]. Acta Obstet Gynecol Scand 2003; 82: 330-334.
[64]Chwalisz K; Larsen L; Mattia-Goldberg C, et al. A randomized controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyoma[J]. Fertility And Sterility. 2007,87(6):1399-1412.
[65]刘玉琴.细胞培养实验手册[M].北京：人民军医出版社.2009,6：3-5.
[66]李珍,赵志亮,郭述真.人子宫平滑肌细胞的原代培养[J].山西医药杂志.2007,36(12)：1101-1102.
[67]肖柳英,张丹,冯昭明,等.荔枝核对小鼠抗肿瘤作用研究[J].中药材,2004,7,27(4)：517.
[68]吕俊华,沈文娟,韦笑梅,等.荔枝核提取物对荷瘤小鼠肿瘤细胞Bax和Bc1-2蛋白表达的影响[J].中成药,2008,30(9)：1381.
[69]刘海洲,刘均红.海藻多糖的生物活性及医药应用研究新进展[J].化工科技市场,2005,8：29.
[70]王颖,马安伦,张惠珍,等.牡蛎提取物抗肿瘤作用的实验研究[J].中国海洋药物,1997,1：18-22.
[71]欧阳勇.莪术挥发油对实验动物子宫肌瘤抑制作用影响研究[J].中国现代药物应用,2008,12,2(24)：14.
[72]魏丽春,李庆军.益母草的药理与临床研究进展[J].西北药学杂志.2009,24(4)：333-335
[73]王一涛,王家葵,杨奎等.续断的药理学研究[J].中药药理与临床,1996(3)：20-23.
[74]黄爱华.宫瘤清含药血清对子宫肌瘤细胞ER、PR、EGFR、IGF-1R及肌瘤细胞凋亡的实验研究.成都中医药大学博士论文[J].2005.31-32.
[75]Kawaguchi K, Fujii S, Konishi, et al. Ultrastructural study of cultured muscle cell from uterine leiomyoma and myometrium under the influence of sex steroids [J]. Gynecol Oncol,1985,21:32.
[76]杨彦,王胜军,樊洁,等.不同浓度米非司酮对体外培养子宫肌瘤细胞生长的影响[J].江苏大学学报(医学版).2003,13(3)：123-125.
[77]司徒镇强,吴军正.细胞培养[M].第2版.西安：世界图书出版公司.2007.1：200-201.
[78]Bradon DD, Bethea CL, Strawn EY, et al. Progesterone receptor messenger ribonucleic acid and protein are over expressed in human uterine leiomyomas [J].AM J Obstet Gynecol,1993,169:78.
[79]Mcbean JH, Brumsted JR, Stirewalt WS. In vivo estrogen regulation of epidermal growth factor receptor in human endometrium[J]. J Clin Endocrinol Metab,1997,82(5):1467-1471.19.
[80]李卫平,林其德,严隽鸿,等.子宫平滑肌瘤细胞增殖与表皮生长因子受体关系研究子宫肌瘤细胞膜上[J].上海医学.2002,25(4)：202-204.